Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Market Cap : 311.40M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 311.40M |
| August 21, 2026 | 317.76M |
| August 20, 2026 | 320.39M |
| August 19, 2026 | 326.37M |
| August 18, 2026 | 326.91M |
| August 17, 2026 | 331.76M |
| August 14, 2026 | 333.91M |
| August 13, 2026 | 386.15M |
| August 12, 2026 | 387.77M |
| August 11, 2026 | 388.85M |
| August 10, 2026 | 387.86M |
| August 07, 2026 | 388.83M |
| August 06, 2026 | 385.28M |
| August 05, 2026 | 388.72M |
| August 04, 2026 | 393.03M |
| August 03, 2026 | 400.25M |
| July 31, 2026 | 408.11M |
| July 30, 2026 | 401.43M |
| July 29, 2026 | 400.25M |
| July 28, 2026 | 403.91M |
| July 27, 2026 | 414.68M |
| July 24, 2026 | 417.40M |
| July 23, 2026 | 403.91M |
| July 22, 2026 | 401.76M |
| July 21, 2026 | 408.22M |
| Date | Value |
|---|---|
| July 20, 2026 | 414.68M |
| July 17, 2026 | 418.18M |
| July 16, 2026 | 429.76M |
| July 15, 2026 | 403.80M |
| July 14, 2026 | 400.57M |
| July 13, 2026 | 393.14M |
| July 10, 2026 | 397.10M |
| July 09, 2026 | 394.97M |
| July 08, 2026 | 397.45M |
| July 07, 2026 | 391.57M |
| July 06, 2026 | 387.75M |
| July 02, 2026 | 367.29M |
| July 01, 2026 | 387.43M |
| June 30, 2026 | 393.25M |
| June 29, 2026 | 425.45M |
| June 26, 2026 | 425.56M |
| June 25, 2026 | 414.68M |
| June 24, 2026 | 397.46M |
| June 23, 2026 | 388.97M |
| June 22, 2026 | 389.50M |
| June 18, 2026 | 386.82M |
| June 17, 2026 | 396.49M |
| June 16, 2026 | 396.38M |
| June 15, 2026 | 394.88M |
| June 12, 2026 | 364.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.568B |
| Daré Bioscience, Inc. | 12.36M |
| Eton Pharmaceuticals, Inc. | 1.761B |
| ANI Pharmaceuticals, Inc. | 1.702B |
| Corcept Therapeutics, Inc. | 13.25B |
Market Cap Related Metrics
| PE Ratio | 10.99 |
| PS Ratio | 2.300 |
| Price to Book Value | 2.971 |
| Price to Free Cash Flow | 18.51 |
| Price | 0.2891 |
| Earnings Yield | 9.10% |
| Operating PE Ratio | 9.064 |
| Normalized PE Ratio | 35.69 |